Table 6.
Incremental cost effectiveness analysis results
| Analysis |
Intervention |
Control |
ICC |
|---|---|---|---|
| Group follow-up N = 216 | Individual follow-up N = 221 | ||
|
Cost analysis |
|
|
|
| Total healthcare cost (€) |
|
|
|
| Mean (SD) |
3,551 (566) |
4,337 (551) |
0.016 |
| Incremental analysis (difference in means; intervention versus control) |
−772 (95% CI, −1,415 to −128; P = 0.020) |
|
|
|
Effectiveness analysis |
|
|
|
| QALYs gained |
|
|
|
| Mean (SD) |
1.31 (0.12) |
1.35 (0.12) |
0.033 |
| Incremental analysis (difference in means; intervention versus control) |
|
|
|
| |
−0.04 (95% CI, −0.08 to 0.01; P = 0.052) |
|
|
| |
Cost effectiveness analysis (probability that treatment is cost effective at λ |
||
| Threshold value (λ) |
|
|
|
| λ = €0 |
1.000 |
0.000 |
|
| λ = €5,000 |
1.000 |
0.000 |
|
| λ = €10,000 |
0.996 |
0.004 |
|
| λ = €15,000 |
0.762 |
0.238 |
|
| λ = €20,000 |
0.400 |
0.600 |
|
| λ = €25,000 |
0.204 |
0.796 |
|
| λ = €30,000 |
0.119 |
0.881 |
|
| λ = €35,000 |
0.078 |
0.922 |
|
| λ = €40,000 |
0.049 |
0.951 |
|
| λ = €45,000 | 0.033 | 0.967 | |
λ or threshold value of the maximum that the health system would be willing to pay per QALY gained. ICC, intra-class coefficient; QALY, quality-adjusted life year.